Authors: ZAROGOULIDIS K PAPAGIANNIS A ZIOGAS E FAHANTIDOU E DERMITZAKIS G GIOULEKAS D VAMVALIS C

Citation: K. Zarogoulidis et al., MANAGEMENT OF CHEMOTHERAPY-RELATED ANEMIA WITH LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH SMALL-CELL LUNG-CANCER, European journal of cancer, 33(14), 1997, pp. 2428-2431

Authors: ZAROGOULIDIS K ZIOGAS E PAPAGIANNIS A CHARITOPOULOS K DIMITRIADIS K ECONOMIDES D MAGLAVERAS N

Citation: K. Zarogoulidis et al., INTERFERON ALPHA-2A AND COMBINED CHEMOTHERAPY AS FIRST LINE TREATMENTIN SCLC PATIENTS - A RANDOMIZED TRIAL, Lung cancer, 15(2), 1996, pp. 197-205

Authors: ZAROGOULIDIS K ZIOGAS E DERMITZAKIS G PAPAGIANNIS A DIMITRIADIS K

Citation: K. Zarogoulidis et al., THE SURVIVAL BENEFIT OF MAINTENANCE THERAPY OF NSCLC PTS RESPONDING TO INITIAL TREATMENT - A RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 1112-1112